Probably no drug has ever attracted such intense controversy as hydroxychloroquine in the Covid-19 era. Yet the evidence for its efficacy in treating Covid-19 at the early stage is straightforward. Virtually 100% of early treatment studies have recorded benefit from the drug. Accordingly, the controversy over early HCQ treatment has not arisen because of any insufficiency in the evidence. As the existence of this evidence is our first Stubborn Truth it’s worth a look to see what it consists of.Below is a list of all the studies that examined the…
Read More